Advertisement

Index by author

March 01, 1975; Volume 192,Issue 3

A

  1. Aeschbacher, H U

    1. The effect of caffeine on barbiturate sleeping time and brain level.
      H U Aeschbacher, J Atkinson and B Domahidy
      Journal of Pharmacology and Experimental Therapeutics March 1975, 192 (3) 635-641;

  2. Akera, T

    1. The effects of age on the development of tolerance to and physical dependence on morphine in rats.
      M Nozaki, T Akera, C Y Lee and T M Brody
      Journal of Pharmacology and Experimental Therapeutics March 1975, 192 (3) 506-512;

  3. Atkinson, J

    1. The effect of caffeine on barbiturate sleeping time and brain level.
      H U Aeschbacher, J Atkinson and B Domahidy
      Journal of Pharmacology and Experimental Therapeutics March 1975, 192 (3) 635-641;

B

  1. Bell, R D

    1. Effects of chronic morphine administration on the reproductive system of the male rat.
      T J Cicero, E R Meyer, W G Wiest, J W Olney and R D Bell
      Journal of Pharmacology and Experimental Therapeutics March 1975, 192 (3) 542-548;

  2. Benninger, C

    1. Effects of prenylamine on cardiac membrane currents and contractility.
      H G Haas, R Kern, C Benninger and H M Einwächter
      Journal of Pharmacology and Experimental Therapeutics March 1975, 192 (3) 688-701;

  3. Berndt, W O

    1. Effect of biliary stasis and hepatotoxins on the excretion of iopanoate in the rat.
      W J Cooke, W O Berndt and G H Mudge
      Journal of Pharmacology and Experimental Therapeutics March 1975, 192 (3) 618-629;

  4. Bernstein, J

    1. Effects of chronic ethanol treatment and thyroxine administration on ethanol metabolism and liver oxidative capacity.
      Y Israel, L Videla, V Fernandez-Videla and J Bernstein
      Journal of Pharmacology and Experimental Therapeutics March 1975, 192 (3) 565-574;
    2. Hormonal influences in the development of the hypermetabolic state of the liver produced by chronic administration of ethanol.
      J Bernstein, L Videla and Y Israel
      Journal of Pharmacology and Experimental Therapeutics March 1975, 192 (3) 583-591;

  5. Boisse, N R

    1. Tolerance characteristics produced during the maximally tolerable chronic pentobarbital dosing in the cat.
      M Okamoto, H C Rosenberg and N R Boisse
      Journal of Pharmacology and Experimental Therapeutics March 1975, 192 (3) 555-569;

  6. Brody, T M

    1. The effects of age on the development of tolerance to and physical dependence on morphine in rats.
      M Nozaki, T Akera, C Y Lee and T M Brody
      Journal of Pharmacology and Experimental Therapeutics March 1975, 192 (3) 506-512;

C

  1. Chandler, J M

    1. The effects of methadone on maternal-fetal interactions in the rat.
      J M Chandler, P W Robie, J C Schoolar and M M Desmond
      Journal of Pharmacology and Experimental Therapeutics March 1975, 192 (3) 549-554;

  2. Chiueh, C C

    1. D-amphetamine-induced release of "newly synthesized" and "stored" dopamine from the caudate nucleus in vivo.
      C C Chiueh and K E Moore
      Journal of Pharmacology and Experimental Therapeutics March 1975, 192 (3) 642-653;

  3. Cicero, T J

    1. Effects of chronic morphine administration on the reproductive system of the male rat.
      T J Cicero, E R Meyer, W G Wiest, J W Olney and R D Bell
      Journal of Pharmacology and Experimental Therapeutics March 1975, 192 (3) 542-548;

  4. Cooke, W J

    1. Effect of biliary stasis and hepatotoxins on the excretion of iopanoate in the rat.
      W J Cooke, W O Berndt and G H Mudge
      Journal of Pharmacology and Experimental Therapeutics March 1975, 192 (3) 618-629;

  5. Corrêa, F M

    1. Central site of the hypertensive action of bradykinin.
      F M Corrêa and F G Graeff
      Journal of Pharmacology and Experimental Therapeutics March 1975, 192 (3) 670-676;

  6. Côté, M G

    1. Potentiation of carbon tetrachloride-induced hepatotoxicity in alloxan- or strepto- zotocin-diabetic rats.
      G K Hanasono, M G Côté and G L Plaa
      Journal of Pharmacology and Experimental Therapeutics March 1975, 192 (3) 592-604;

D

  1. Darrah, H K

    1. Uptake into brain proteins of 35S-methionine during morphine tolerance.
      D W Lang, H K Darrah, J Hedley-Whyte and L H Laasberg
      Journal of Pharmacology and Experimental Therapeutics March 1975, 192 (3) 521-530;

  2. Desmond, M M

    1. The effects of methadone on maternal-fetal interactions in the rat.
      J M Chandler, P W Robie, J C Schoolar and M M Desmond
      Journal of Pharmacology and Experimental Therapeutics March 1975, 192 (3) 549-554;

  3. Domahidy, B

    1. The effect of caffeine on barbiturate sleeping time and brain level.
      H U Aeschbacher, J Atkinson and B Domahidy
      Journal of Pharmacology and Experimental Therapeutics March 1975, 192 (3) 635-641;

  4. Drezner, M K

    1. Inhibition of chondromucoprotein synthesis: an extraneuronal effect of nerve growth factor.
      G S Eisenbarth, M K Drezner and H E Lebovitz
      Journal of Pharmacology and Experimental Therapeutics March 1975, 192 (3) 630-634;

E

  1. Edelman, I

    1. Further properties of stereospecific opiate binding sites in rat brain: on the nature of the sodium effect.
      E J Simon, J M Hiller, J Groth and I Edelman
      Journal of Pharmacology and Experimental Therapeutics March 1975, 192 (3) 531-537;

  2. Einwächter, H M

    1. Effects of prenylamine on cardiac membrane currents and contractility.
      H G Haas, R Kern, C Benninger and H M Einwächter
      Journal of Pharmacology and Experimental Therapeutics March 1975, 192 (3) 688-701;

  3. Eisenbarth, G S

    1. Inhibition of chondromucoprotein synthesis: an extraneuronal effect of nerve growth factor.
      G S Eisenbarth, M K Drezner and H E Lebovitz
      Journal of Pharmacology and Experimental Therapeutics March 1975, 192 (3) 630-634;

F

  1. Fernandez-Videla, V

    1. Effects of chronic ethanol treatment and thyroxine administration on ethanol metabolism and liver oxidative capacity.
      Y Israel, L Videla, V Fernandez-Videla and J Bernstein
      Journal of Pharmacology and Experimental Therapeutics March 1975, 192 (3) 565-574;

  2. Finlay, E

    1. The cardiovascular actions of dopamine and the effects of central and peripheral catecholaminergic receptor blocking drugs.
      P E Setler, R G Pendleton and E Finlay
      Journal of Pharmacology and Experimental Therapeutics March 1975, 192 (3) 702-712;

  3. Flattery, K V

    1. Ethanol metabolism and liver oxidative capacity in cold acclimation.
      L Videla, K V Flattery, E A Sellers and Y Israel
      Journal of Pharmacology and Experimental Therapeutics March 1975, 192 (3) 575-582;

G

  1. Ganong, W F

    1. Studies concerning the mechanism of suppression of renin secretion by clonidine.
      I A Reid, D M MacDonald, B Pachnis and W F Ganong
      Journal of Pharmacology and Experimental Therapeutics March 1975, 192 (3) 713-721;

  2. George, W J

    1. Influence of prostaglandins E1 and F2alpha on pulmonary vascular resistance, isolated lobar vessels and cyclic nucleotide levels.
      P J Kadowitz, P D Joiner, A L Hyman and W J George
      Journal of Pharmacology and Experimental Therapeutics March 1975, 192 (3) 677-687;

  3. Gilbert, P E

    1. Antagonism of the convulsant effects of heroin, d-propoxyphene, meperidine, normeperidine and thebaine by naloxone in mice.
      P E Gilbert and W R Martin
      Journal of Pharmacology and Experimental Therapeutics March 1975, 192 (3) 538-541;

  4. Graeff, F G

    1. Central site of the hypertensive action of bradykinin.
      F M Corrêa and F G Graeff
      Journal of Pharmacology and Experimental Therapeutics March 1975, 192 (3) 670-676;

  5. Groth, J

    1. Further properties of stereospecific opiate binding sites in rat brain: on the nature of the sodium effect.
      E J Simon, J M Hiller, J Groth and I Edelman
      Journal of Pharmacology and Experimental Therapeutics March 1975, 192 (3) 531-537;

H

  1. Haas, H G

    1. Effects of prenylamine on cardiac membrane currents and contractility.
      H G Haas, R Kern, C Benninger and H M Einwächter
      Journal of Pharmacology and Experimental Therapeutics March 1975, 192 (3) 688-701;

  2. Hanasono, G K

    1. Potentiation of carbon tetrachloride-induced hepatotoxicity in alloxan- or strepto- zotocin-diabetic rats.
      G K Hanasono, M G Côté and G L Plaa
      Journal of Pharmacology and Experimental Therapeutics March 1975, 192 (3) 592-604;

  3. Hedley-Whyte, J

    1. Uptake into brain proteins of 35S-methionine during morphine tolerance.
      D W Lang, H K Darrah, J Hedley-Whyte and L H Laasberg
      Journal of Pharmacology and Experimental Therapeutics March 1975, 192 (3) 521-530;

  4. Hiller, J M

    1. Further properties of stereospecific opiate binding sites in rat brain: on the nature of the sodium effect.
      E J Simon, J M Hiller, J Groth and I Edelman
      Journal of Pharmacology and Experimental Therapeutics March 1975, 192 (3) 531-537;

  5. Holtzman, S G

    1. Quantification of the analgesic activity of narcotic antagonists by a modified hot-plate procedure.
      J P O'Callaghan and S G Holtzman
      Journal of Pharmacology and Experimental Therapeutics March 1975, 192 (3) 497-505;

  6. Hunter, A L

    1. Biliary excretion of colchicine.
      A L Hunter and C D Klaassen
      Journal of Pharmacology and Experimental Therapeutics March 1975, 192 (3) 605-617;

  7. Hyman, A L

    1. Influence of prostaglandins E1 and F2alpha on pulmonary vascular resistance, isolated lobar vessels and cyclic nucleotide levels.
      P J Kadowitz, P D Joiner, A L Hyman and W J George
      Journal of Pharmacology and Experimental Therapeutics March 1975, 192 (3) 677-687;

I

  1. Israel, Y

    1. Effects of chronic ethanol treatment and thyroxine administration on ethanol metabolism and liver oxidative capacity.
      Y Israel, L Videla, V Fernandez-Videla and J Bernstein
      Journal of Pharmacology and Experimental Therapeutics March 1975, 192 (3) 565-574;
    2. Ethanol metabolism and liver oxidative capacity in cold acclimation.
      L Videla, K V Flattery, E A Sellers and Y Israel
      Journal of Pharmacology and Experimental Therapeutics March 1975, 192 (3) 575-582;
    3. Hormonal influences in the development of the hypermetabolic state of the liver produced by chronic administration of ethanol.
      J Bernstein, L Videla and Y Israel
      Journal of Pharmacology and Experimental Therapeutics March 1975, 192 (3) 583-591;

J

  1. Johnson, A R

    1. The uptake of a substituted acridone by rat mast cells in relationship to histamine release: a possible indicator of exocytosis-induced expansion of the plasma membrane.
      C R Kinsolving, A R Johnson and N C Moran
      Journal of Pharmacology and Experimental Therapeutics March 1975, 192 (3) 654-669;

  2. Joiner, P D

    1. Influence of prostaglandins E1 and F2alpha on pulmonary vascular resistance, isolated lobar vessels and cyclic nucleotide levels.
      P J Kadowitz, P D Joiner, A L Hyman and W J George
      Journal of Pharmacology and Experimental Therapeutics March 1975, 192 (3) 677-687;

K

  1. Kadowitz, P J

    1. Influence of prostaglandins E1 and F2alpha on pulmonary vascular resistance, isolated lobar vessels and cyclic nucleotide levels.
      P J Kadowitz, P D Joiner, A L Hyman and W J George
      Journal of Pharmacology and Experimental Therapeutics March 1975, 192 (3) 677-687;

  2. Kern, R

    1. Effects of prenylamine on cardiac membrane currents and contractility.
      H G Haas, R Kern, C Benninger and H M Einwächter
      Journal of Pharmacology and Experimental Therapeutics March 1975, 192 (3) 688-701;

  3. Kinsolving, C R

    1. The uptake of a substituted acridone by rat mast cells in relationship to histamine release: a possible indicator of exocytosis-induced expansion of the plasma membrane.
      C R Kinsolving, A R Johnson and N C Moran
      Journal of Pharmacology and Experimental Therapeutics March 1975, 192 (3) 654-669;

  4. Klaassen, C D

    1. Biliary excretion of colchicine.
      A L Hunter and C D Klaassen
      Journal of Pharmacology and Experimental Therapeutics March 1975, 192 (3) 605-617;

L

  1. Laasberg, L H

    1. Uptake into brain proteins of 35S-methionine during morphine tolerance.
      D W Lang, H K Darrah, J Hedley-Whyte and L H Laasberg
      Journal of Pharmacology and Experimental Therapeutics March 1975, 192 (3) 521-530;

  2. Lang, D W

    1. Uptake into brain proteins of 35S-methionine during morphine tolerance.
      D W Lang, H K Darrah, J Hedley-Whyte and L H Laasberg
      Journal of Pharmacology and Experimental Therapeutics March 1975, 192 (3) 521-530;

  3. Lebovitz, H E

    1. Inhibition of chondromucoprotein synthesis: an extraneuronal effect of nerve growth factor.
      G S Eisenbarth, M K Drezner and H E Lebovitz
      Journal of Pharmacology and Experimental Therapeutics March 1975, 192 (3) 630-634;

  4. Lee, C Y

    1. The effects of age on the development of tolerance to and physical dependence on morphine in rats.
      M Nozaki, T Akera, C Y Lee and T M Brody
      Journal of Pharmacology and Experimental Therapeutics March 1975, 192 (3) 506-512;

M

  1. MacDonald, D M

    1. Studies concerning the mechanism of suppression of renin secretion by clonidine.
      I A Reid, D M MacDonald, B Pachnis and W F Ganong
      Journal of Pharmacology and Experimental Therapeutics March 1975, 192 (3) 713-721;

  2. Martin, W R

    1. Antagonism of the convulsant effects of heroin, d-propoxyphene, meperidine, normeperidine and thebaine by naloxone in mice.
      P E Gilbert and W R Martin
      Journal of Pharmacology and Experimental Therapeutics March 1975, 192 (3) 538-541;

  3. Meyer, E R

    1. Effects of chronic morphine administration on the reproductive system of the male rat.
      T J Cicero, E R Meyer, W G Wiest, J W Olney and R D Bell
      Journal of Pharmacology and Experimental Therapeutics March 1975, 192 (3) 542-548;

  4. Moore, K E

    1. D-amphetamine-induced release of "newly synthesized" and "stored" dopamine from the caudate nucleus in vivo.
      C C Chiueh and K E Moore
      Journal of Pharmacology and Experimental Therapeutics March 1975, 192 (3) 642-653;

  5. Moran, N C

    1. The uptake of a substituted acridone by rat mast cells in relationship to histamine release: a possible indicator of exocytosis-induced expansion of the plasma membrane.
      C R Kinsolving, A R Johnson and N C Moran
      Journal of Pharmacology and Experimental Therapeutics March 1975, 192 (3) 654-669;

  6. Mudge, G H

    1. Effect of biliary stasis and hepatotoxins on the excretion of iopanoate in the rat.
      W J Cooke, W O Berndt and G H Mudge
      Journal of Pharmacology and Experimental Therapeutics March 1975, 192 (3) 618-629;

N

  1. Nozaki, M

    1. The effects of age on the development of tolerance to and physical dependence on morphine in rats.
      M Nozaki, T Akera, C Y Lee and T M Brody
      Journal of Pharmacology and Experimental Therapeutics March 1975, 192 (3) 506-512;

O

  1. O'Callaghan, J P

    1. Quantification of the analgesic activity of narcotic antagonists by a modified hot-plate procedure.
      J P O'Callaghan and S G Holtzman
      Journal of Pharmacology and Experimental Therapeutics March 1975, 192 (3) 497-505;

  2. Okamoto, M

    1. Tolerance characteristics produced during the maximally tolerable chronic pentobarbital dosing in the cat.
      M Okamoto, H C Rosenberg and N R Boisse
      Journal of Pharmacology and Experimental Therapeutics March 1975, 192 (3) 555-569;

  3. Olney, J W

    1. Effects of chronic morphine administration on the reproductive system of the male rat.
      T J Cicero, E R Meyer, W G Wiest, J W Olney and R D Bell
      Journal of Pharmacology and Experimental Therapeutics March 1975, 192 (3) 542-548;

P

  1. Pachnis, B

    1. Studies concerning the mechanism of suppression of renin secretion by clonidine.
      I A Reid, D M MacDonald, B Pachnis and W F Ganong
      Journal of Pharmacology and Experimental Therapeutics March 1975, 192 (3) 713-721;

  2. Pendleton, R G

    1. The cardiovascular actions of dopamine and the effects of central and peripheral catecholaminergic receptor blocking drugs.
      P E Setler, R G Pendleton and E Finlay
      Journal of Pharmacology and Experimental Therapeutics March 1975, 192 (3) 702-712;

  3. Peters, M A

    1. Development of a "blood-brain barrier" to methadone in the newborn rat.
      M A Peters
      Journal of Pharmacology and Experimental Therapeutics March 1975, 192 (3) 513-520;

  4. Plaa, G L

    1. Potentiation of carbon tetrachloride-induced hepatotoxicity in alloxan- or strepto- zotocin-diabetic rats.
      G K Hanasono, M G Côté and G L Plaa
      Journal of Pharmacology and Experimental Therapeutics March 1975, 192 (3) 592-604;

R

  1. Reid, I A

    1. Studies concerning the mechanism of suppression of renin secretion by clonidine.
      I A Reid, D M MacDonald, B Pachnis and W F Ganong
      Journal of Pharmacology and Experimental Therapeutics March 1975, 192 (3) 713-721;

  2. Robie, P W

    1. The effects of methadone on maternal-fetal interactions in the rat.
      J M Chandler, P W Robie, J C Schoolar and M M Desmond
      Journal of Pharmacology and Experimental Therapeutics March 1975, 192 (3) 549-554;

  3. Rosenberg, H C

    1. Tolerance characteristics produced during the maximally tolerable chronic pentobarbital dosing in the cat.
      M Okamoto, H C Rosenberg and N R Boisse
      Journal of Pharmacology and Experimental Therapeutics March 1975, 192 (3) 555-569;

S

  1. Schoolar, J C

    1. The effects of methadone on maternal-fetal interactions in the rat.
      J M Chandler, P W Robie, J C Schoolar and M M Desmond
      Journal of Pharmacology and Experimental Therapeutics March 1975, 192 (3) 549-554;

  2. Sellers, E A

    1. Ethanol metabolism and liver oxidative capacity in cold acclimation.
      L Videla, K V Flattery, E A Sellers and Y Israel
      Journal of Pharmacology and Experimental Therapeutics March 1975, 192 (3) 575-582;

  3. Setler, P E

    1. The cardiovascular actions of dopamine and the effects of central and peripheral catecholaminergic receptor blocking drugs.
      P E Setler, R G Pendleton and E Finlay
      Journal of Pharmacology and Experimental Therapeutics March 1975, 192 (3) 702-712;

  4. Simon, E J

    1. Further properties of stereospecific opiate binding sites in rat brain: on the nature of the sodium effect.
      E J Simon, J M Hiller, J Groth and I Edelman
      Journal of Pharmacology and Experimental Therapeutics March 1975, 192 (3) 531-537;

V

  1. Videla, L

    1. Effects of chronic ethanol treatment and thyroxine administration on ethanol metabolism and liver oxidative capacity.
      Y Israel, L Videla, V Fernandez-Videla and J Bernstein
      Journal of Pharmacology and Experimental Therapeutics March 1975, 192 (3) 565-574;
    2. Ethanol metabolism and liver oxidative capacity in cold acclimation.
      L Videla, K V Flattery, E A Sellers and Y Israel
      Journal of Pharmacology and Experimental Therapeutics March 1975, 192 (3) 575-582;
    3. Hormonal influences in the development of the hypermetabolic state of the liver produced by chronic administration of ethanol.
      J Bernstein, L Videla and Y Israel
      Journal of Pharmacology and Experimental Therapeutics March 1975, 192 (3) 583-591;

W

  1. Wiest, W G

    1. Effects of chronic morphine administration on the reproductive system of the male rat.
      T J Cicero, E R Meyer, W G Wiest, J W Olney and R D Bell
      Journal of Pharmacology and Experimental Therapeutics March 1975, 192 (3) 542-548;
Back to top

In this issue

Advertisement